Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical rules for phenytoin dosing

M D Privitera1

  • 1Department of Neurology, University of Cincinnati Medical Center, OH.

The Annals of Pharmacotherapy
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Simple phenytoin (PHT) dosing rules were developed using computer simulations and validated with patient data. These rules help clinicians safely adjust PHT dosage, minimizing toxic plasma concentrations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.

Acta neurologica Scandinavica·2005
Same author

Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study.

Acta neurologica Scandinavica·2004
Same author

An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.

Seizure·2003
Same author

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.

Acta neurologica Scandinavica·2003
Same author

Vagus nerve stimulation for partial seizures.

The Cochrane database of systematic reviews·2002
Same author

Postictal language dysfunction in complex partial seizures: effect of contralateral ictal spread.

Neurology·2001

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Pharmacology
  • Epilepsy Management

Background:

  • Phenytoin (PHT) dosing requires careful management to avoid toxicity.
  • Accurate PHT dosage is crucial for effective epilepsy treatment.
  • Existing dosing methods may lack simplicity and real-time applicability.

Purpose of the Study:

  • To create straightforward clinical guidelines for adjusting phenytoin dosage.
  • To validate the safety and accuracy of these new dosing rules using patient data.
  • To reduce the incidence of potentially toxic PHT plasma concentrations.

Main Methods:

  • Computer simulations were employed to analyze pharmacokinetic data from 45 patients.
  • Bayesian methodology was used to predict PHT plasma concentrations following dosage adjustments.

Related Experiment Videos

  • Dosing rules were formulated to keep PHT levels below 25 micrograms/mL in over 90% of cases.

    • Main Results:

    • Dosing rules were established: +100 mg/d for PHT < 7 mcg/mL, +50 mg/d for 7-12 mcg/mL, +30 mg/d for >= 12 mcg/mL.
    • Testing on 77 patients showed 0% toxicity when rules were followed.
    • Exceeding the rules led to toxic PHT levels in 36% of cases.

    Conclusions:

    • The developed dosing rules offer a simple and effective method for PHT dosage adjustments.
    • These rules demonstrate accuracy and safety when retrospectively applied to patient data.
    • Clinical implementation of these rules can aid in optimizing PHT therapy and patient outcomes.